Accuray's CyberKnife and Radixact robotic radiation therapy systems treat cancer with sub-millimetre precision, installed in over 1,100 centres in 80 countries.
Robotaxi fleets, self-driving trucks, and autonomous public transit deployment across global markets. Accuray's automation score of 2 reflects its R&D intensity ($0.12B annually) and AI patent portfolio of 210 patents.
| # | Company | Automation Score | AI Patents | R&D ($B) |
|---|---|---|---|---|
| 1 | Tesla | 892 | $4.5B | |
| 2 | Baidu Apollo | 2100 | $2.4B | |
| 3 | Mobileye | 1680 | $1.9B | |
| 4 | Waymo | 1340 | $3.0B | |
| 5 | Cruise (GM) | 760 | $2.0B | |
| 6 | Pony.ai | 1050 | $0.7B | |
| 7 | WeRide | 940 | $0.8B | |
| 8 | Aurora Innovation | 580 | $1.1B | |
| 9 | Zoox | 420 | $1.2B | |
| 10 | Motional | 430 | $1.0B |